Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bionano Genomics Inc BNGO

Technology Scientific & Technical Instruments
Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform... see more

Recent & Breaking News (NDAQ:BNGO)

Bionano Announces the Final Speaker Lineup for 2024 Symposium with 33 OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications

GlobeNewswire January 19, 2024

Bionano Announces Peer-Reviewed Publication from its Clinical Study Designed to Support OGM as Part of Standard of Care (SOC) in Genetic Disease Testing

GlobeNewswire January 11, 2024

Bionano Announces 2024 Symposium: Four Consecutive Days of OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications

GlobeNewswire January 10, 2024

Bionano Reports Preliminary Fourth Quarter and Full-Year 2023 Results

GlobeNewswire January 8, 2024

OGM Added to International System for Human Cytogenomic Nomenclature

GlobeNewswire January 3, 2024

International Consortium Publishes Comprehensive Roadmap for the Clinical Implementation of OGM in Hematological Malignancy Applications

GlobeNewswire January 3, 2024

Bionano Announces Significant Upgrades to its Bionano Solve Pipeline and its VIA(TM) Software for OGM Data Analysis in Constitutional Genetic Disease Research

GlobeNewswire December 28, 2023

Bionano Announces Publication of Largest Prospective Prenatal Study Comparing OGM to Chromosomal Microarray Analysis and Karyotyping

GlobeNewswire December 26, 2023

Cancers Journal Publishes Special Issue Dedicated to OGM's Impact on Hematological Malignancy Research

GlobeNewswire December 14, 2023

Bionano Laboratories Announces Publication of the Analytical Validation of its OGM-Based Laboratory Developed Test for Hematological Malignancies and Additional Multi-Site Technical Evaluation of OGM

GlobeNewswire December 12, 2023

Bionano Announces Presentations Featuring OGM Utility Across Blood Cancer Research at the American Society of Hematology (ASH) Annual Meeting

GlobeNewswire December 6, 2023

Study Shows that OGM Plays an Important Role in Efficient Diagnosis of FSHD

GlobeNewswire November 30, 2023

Bionano Announces Publication Demonstrating Utility of OGM to Assess Genome Integrity of CRISPR-Edited Cells as Part of Gene Therapy Development

GlobeNewswire November 29, 2023

LeddarTech Appoints Chris Stewart as Chief Financial Officer

GlobeNewswire November 15, 2023

Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual Meeting

GlobeNewswire November 14, 2023

Bionano Reports Third Quarter 2023 Results and Highlights Recent Business Progress

GlobeNewswire November 8, 2023

Thompson and Thompson Genetics and Genomics in Medicine Includes OGM in Latest Edition, Notes Workflow's Performance and Ability to Detect More SVs than LRS at Lower Cost

GlobeNewswire November 2, 2023

Bionano to Present at the 2023 Stifel Healthcare Conference

GlobeNewswire November 1, 2023

Bionano to Report Third Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 8, 2023

GlobeNewswire November 1, 2023

Bionano Announces Presentation of OGM Utility Across Key Applications at the American Society of Human Genetics (ASHG) Annual Meeting

GlobeNewswire October 26, 2023